Establishing a diagnosis as soon as possible

Improve the lives of patients of all ages affected by mitochondrial diseases

There is no cure for mitochondrial diseases, but several different treatment options and approaches can help reduce symptoms or delay or prevent the progression of the disease. CentoMito® is CENTOGENE's targeted genetic testing for the diagnosis of mitochondrial diseases.

  1. Mitochondrial Disease Testing

Mitochondrial disease testing

With CentoMito® CENTOGENE has designed a special panel for diagnostics of mitochondrial diseases. By targeting nuclear encoded genes as well as mitochondrial encoded genes, this panel provides a comprehensive test in patients with a demonstrated mitochondrial deficiency on biopsy material or a suspicion of mitochondrial disorders based on the patient’s symptoms.

Find your genetic test

Order Your Test


What are mitochondrial diseases?

Mitochondrial diseases are genetic conditions that occur when mitochondria fail to produce enough energy for the cell.

Genetic mutations in the mitochondrial genome, or nuclear genes, encoding proteins that maintain the function of the mitochondria, causing symptoms mainly in the organs where energy consumption is high. These organs are eye, liver, kidney, pancreas, blood, inner ear, colon, skeletal muscle, heart and brain.

Mitochondrial diseases are estimated to affect 1 in 5,000–8,500 people.

Downloads for Mitochondrial diseases

Who should get tested for mitochondrial diseases?

  • Individuals with clinical symptoms characteristic of a specific mitochondrial disorder such as progressive external ophthalmoplegia, muscle biopsy findings, stroke-like episodes, etc.
  • Individuals with any progressive multisystem disorder of unknown etiology
  • Individuals with multiple complex neurologic features or a single neurological symptom with other system involvement
  • Children presenting with lactic acidosis
  • Presymptomatic testing for at-risk family members

Latest scientific articles

Genetic testing for mitochondrial diseases at CENTOGENE

Click image to enlarge

Test results

  • Positive result – indicates that a previously understood disease-causing mutation was identified. This result can help the physician to assess the risk of experiencing certain symptoms and indicate the best way how to treat the disease. Positive result may also identify family members at risk of having the mutation, and carrier testing may be recommended.
  • Negative result – does not necessarily rule out a mitochondrial disorder, and the patient should be managed according to clinical symptoms. Possible reasons for a negative result could be that the patient may have a mutation in a gene not covered by the testing panel, or it could be a mutation which is not detectable t´with the performed test, or the patient does not have a mitochondrial disorder.
  • Variant of unknown clinical significance (VUS) – indicates that we have identified a change in the DNA, but this change is not known to be associated with a disorder. To clarify the clinical significance of the variant, testing other family members may be helpful.

What tests for diagnostics of mitochondrial diseases are offered by CENTOGENE?

CENTOGENE offers two panels for the diagnostics of mitochondrial diseases:

  • CentoMito® Comprehensive

    Covers the entire mitochondrial genome (100% coverage at >1.000x) along with 372 nuclear genes related to the mitochondrial diseases (mean coverage of 120x, with >94% of bases covered at ≥20x).
    It includes sequence analysis of 372 nuclear encoded mitochondrial proteins and complete mitochondrial genome, with detection of heteroplasmy down to 15%. Large MT gene deletions are also covered by this panel.

  • CentoMito® Genome

    Includes all mitochondrial genes (100% covered >1.000x):
    MT-ND1, MT-ND2, MT-CO1, MT-CO2, MT-ATP8, MT-ATP6, MT-CO3, MT-ND3, MT-ND4L, MT-ND4, MT-ND5, MT-ND6, MT-CYB, MT-TF, MT-RNR1, MT-TV, MT-RNR2, MT-TL1, MT-TI, MT-TQ, MT-TM, MT-TW, MT-TA, MT-TN, MT-TC, MT-TY, MT-TS1, MT-TD, MT-TK, MT-TG, MT-TR, MT-TH, MT-TS2, MT-TL2, MT-TE, MT-TT, MT-TP.
    Large deletions are also covered.

     

What CENTOGENE can do for you

Mitochondrial diseases are difficult to diagnose and they can present symptoms long after birth. To date, there is NO treatment and NO cure for mitochondrial diseases.

To improve quality of life for adults and children affected by mitochondrial disease we need to establish diagnosis as soon as possible and this is possible only using genetic testing.


Download our request form and order your genetic test for mitochondrial diseases now

  • Request form - Whole genetic test portfolio

    Download

CentoCard® – simplify your logistics

Sending patients´ samples as easy as mailing a postcard.

Order now

CentoPortal® – online ordering portal

Manage your genetic testing online supported by CentoCard®.

Read more

Get in touch with our Department of Medical Quality and Counseling

Please call or send us an email with any questions and benefit from our medical consultation services, available both before and after testing.


+49 - 381 - 203 - 652 - 222 

Mon. – Fri. 7 a.m.– 8 p.m. CET • Sat. – Sun. 9 a.m – 5 p.m. CET

Contact us

Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member
Medical Expert Team Member

Our consultation service is available in the following languages:

English, German, French, Italian, Spanish, Dutch, Russian, Arabic, Turkish, Serbian, Macedonian and Bulgarian